Market Access NICE and the controversy over a ‘clinically distinct disease... Payers worldwide are struggling with a new generation of precision medicines that come with a hefty price tag.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
